Bait Bakfar Ltd (TLV:BKFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,443.00
+68.00 (4.95%)
Apr 6, 2026, 2:24 PM IDT
Bait Bakfar Revenue
In the year 2025, Bait Bakfar had annual revenue of 109.62M ILS with 6.02% growth. Bait Bakfar had revenue of 28.28M in the quarter ending December 31, 2025, with 6.98% growth.
Revenue
109.62M
Revenue Growth
+6.02%
P/S Ratio
9.14
Revenue / Employee
482.92K
Employees
227
Market Cap
1.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.62M | 6.23M | 6.02% |
| Dec 31, 2024 | 103.40M | 4.30M | 4.34% |
| Dec 31, 2023 | 99.10M | 6.11M | 6.58% |
| Dec 31, 2022 | 92.99M | 7.60M | 8.90% |
| Dec 31, 2021 | 85.39M | 944.00K | 1.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 930.83M |
| Kamada | 575.31M |
| SofWave Medical | 279.39M |
| BrainsWay | 166.49M |
| Golden House | 46.05M |